A government-commissioned study shows that immunocompromised people have responded well to the third coronavirus vaccine, strengthening the case for giving them a fourth shot, Ynet news reports.
The research by Prof. Galia Rahav, which examined the effectiveness of the booster in immunocompromised people three months after receiving it, shows that both bone marrow and heart transplant recipients respond well to the third dose, the report says.
The study reportedly examined the amount of neutralizing antibodies among 78 kidney transplant recipients, about 120 bone marrow transplant recipients and about 100 heart transplant recipients.
The decision regarding administering the fourth vaccine, which will be based on the research, is set to be made after data has been collected six months following receiving the third shot.
Your next read: ToI Editors' Picks
LIMITED TIME OFFER: Join The Times of Israel Community today and you'll receive a physical book of your choice, carefully curated by our editors.
Choose between two must-reads: When We See You Again by Rachel Goldberg-Polin, a searing portrait of a mother’s grief and strength following unthinkable tragedy;
Or Out of the Sky: Heroism and Rebirth in Nazi Europe by Matti Friedman, the gripping and surprising tale of a forgotten moment during World War II.
As a Community member, you’ll also enjoy our DocuNation series of outstanding Israeli documentary films, an ad-free experience of our site and podcasts, commenting privileges, and more.
CHOOSE YOUR BOOK
CHOOSE YOUR BOOK
Already a member? Sign in to stop seeing this
You're a dedicated reader
We’re really pleased that you’ve read X Times of Israel articles in the past month.
That’s why we started the Times of Israel - to provide discerning readers like you with must-read coverage of Israel and the Jewish world.
So now we have a request. Unlike other news outlets, we haven’t put up a paywall. But as the journalism we do is costly, we invite readers for whom The Times of Israel has become important to help support our work by joining The Times of Israel Community.
For as little as $6 a month you can help support our quality journalism while enjoying The Times of Israel AD-FREE, as well as accessing exclusive content available only to Times of Israel Community members.
Thank you,
David Horovitz, Founding Editor of The Times of Israel
Join Our Community
Join Our Community
Already a member? Sign in to stop seeing this
From the Liveblog of
Wednesday, December 8, 2021
Add ToI as a Preferred Source on Google
